Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 997

1.
2.

[Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].

Mechri A, Saoud M, Khiari G, d'Amato T, Dalery J, Gaha L.

Encephale. 2001 Jan-Feb;27(1):53-9. Review. French.

PMID:
11294039
3.

Phenomenology, aetiology and treatment of schizophrenia.

Javitt DC.

Novartis Found Symp. 2008;289:4-16; discussion 17-22, 87-93.

PMID:
18497092
5.

Glutamatergic theories of schizophrenia.

Javitt DC.

Isr J Psychiatry Relat Sci. 2010;47(1):4-16. Review.

6.
7.

Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.

Mouri A, Noda Y, Enomoto T, Nabeshima T.

Neurochem Int. 2007 Jul-Sep;51(2-4):173-84. Epub 2007 Jun 27. Review.

PMID:
17669558
8.

A review of NMDA receptors and the phencyclidine model of schizophrenia.

Thornberg SA, Saklad SR.

Pharmacotherapy. 1996 Jan-Feb;16(1):82-93. Review.

PMID:
8700797
9.
10.
11.

Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.

Heresco-Levy U.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1113-23. Review.

PMID:
14642971
12.

Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.

Laruelle M, Frankle WG, Narendran R, Kegeles LS, Abi-Dargham A.

Clin Ther. 2005;27 Suppl A:S16-24. Review.

PMID:
16198197
13.

Direct and indirect modulation of the N-methyl D-aspartate receptor.

Marino MJ, Conn PJ.

Curr Drug Targets CNS Neurol Disord. 2002 Feb;1(1):1-16. Review.

PMID:
12769631
14.

A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors.

Javitt DC, Balla A, Sershen H, Lajtha A.

Biol Psychiatry. 1999 Mar 15;45(6):668-79.

PMID:
10187996
15.

Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia.

Lindsley CW, Shipe WD, Wolkenberg SE, Theberge CR, Williams DL Jr, Sur C, Kinney GG.

Curr Top Med Chem. 2006;6(8):771-85. Review.

PMID:
16719816
16.

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.

Bubeníková-Valesová V, Horácek J, Vrajová M, Höschl C.

Neurosci Biobehav Rev. 2008 Jul;32(5):1014-23. doi: 10.1016/j.neubiorev.2008.03.012. Epub 2008 Apr 8. Review.

PMID:
18471877
17.

Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis.

Enomoto T, Noda Y, Nabeshima T.

Methods Find Exp Clin Pharmacol. 2007 May;29(4):291-301. Review.

PMID:
17609743
18.
19.

Metabotropic glutamate receptors: potential drug targets for the treatment of schizophrenia.

Chavez-Noriega LE, Schaffhauser H, Campbell UC.

Curr Drug Targets CNS Neurol Disord. 2002 Jun;1(3):261-81. Review.

PMID:
12769619

Supplemental Content

Support Center